Companies can ask the FDA to waive premarket authorization and investigational device requirements while they collect ...
Foresight’s technology will be integrated into Natera’s Signatera platform and is expected to be launched for clinical use in ...
Needham analysts said Teleflex’s inability to secure a price above the low end of their expectations could reflect “the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback